Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV(+) oral cancer

BACKGROUND: The US is experiencing an epidemic of HPV(+) oropharyngeal cancers (OPC), the rates and burden of which now exceed that for cervical cancer. Immunotherapy targeting programmed death 1 (PD-1) on tumor-infiltrating lymphocytes and/or its ligand PD-L1 on tumor cells, which was effective in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Dorta-Estremera, Stephanie, Hegde, Venkatesh L., Slay, Ravaen B., Sun, Rachel, Yanamandra, Ananta V., Nicholas, Courtney, Nookala, Sita, Sierra, Gloria, Curran, Michael A., Sastry, K. Jagannadha
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749627/
https://ncbi.nlm.nih.gov/pubmed/31533840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0728-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars